December 20, 2019
Investigating a rare genetic immune condition has allowed researchers to uncover a new drug target for a range of autoimmune diseases, which affect one in eight individuals and currently have few therapeutic options. An international team, led by the Garvan Institute of Medical Research, discovered that the protein PI3K is […]